Summit Securities Group’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-145
Closed -$1K 812
2024
Q3
$1K Buy
+145
New +$1K ﹤0.01% 408